Posted by Michael Wonder on 26 May 2022
Prescription medicines: applications under evaluation (May 2022)
26 May 2022 - The TGA has updated its list of applications for new medicines or new uses for existing medicines that are currently under evaluation.
Six new applications were accepted by the TGA for evaluation in May:
- Lenacapavir sodium - new medicine
- Risankizumab - new indication
- Upadacitinib monohydrate - new indication
- Darolutamide - new indication
- Olaparib - new indications x 2
- Zanubrutinib - new indications x 2
